Brad Thompson
Impact in
- Genetics top 5%
- Virus-based gene therapy research
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Viral gastroenteritis research and epidemiology 12
- Viral Infections and Outbreaks Research 3
- SARS-CoV-2 and COVID-19 Research 3
- Genetics 15
- Virus-based gene therapy research 14
- Co-authors
- Matt C. Coffey (11 shared papers)Peter A. Forsyth (3 shared papers)Don G. Morris (2 shared papers)David H. George (2 shared papers)Mark G. Hamilton (2 shared papers)Cheryl Ann Palmer (2 shared papers)Kevin Joseph Harrington (4 shared papers)Hardev Pandha (4 shared papers)
- Journals
- Gene Therapy (4 papers)Biomedicines (4 papers)Clinical Cancer Research (3 papers)Investigational New Drugs (3 papers)Molecular Therapy (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Brad Thompson
23 papers receiving 936 citations
Peers
Comparison fields: 5 of 54
- Genetics 739
- Biotechnology 183
- Infectious Diseases 297
- Oncology 389
- Animal Science and Zoology 76
Countries citing papers authored by Brad Thompson
This map shows the geographic impact of Brad Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Thompson more than expected).
Fields of papers citing papers by Brad Thompson
This network shows the impact of papers produced by Brad Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Thompson. The network helps show where Brad Thompson may publish in the future.
Co-authors
The 25 scholars most cited alongside Brad Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 241 | |
| 2 | 2012 | 165 | |
| 3 | 2008 | 93 | |
| 4 | 2012 | 93 | |
| 5 | 2017 | 78 | |
| 6 | 2004 | 68 | |
| 7 | 2015 | 59 | |
| 8 | 2012 | 52 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 11 | |
| 11 | 2013 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2014 | 8 | |
| 15 | 2015 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2023 | 7 | |
| 20 | A Phase I Study to Evaluate Systemic Wild-type Reovirus (REOLYSIN)(R) in Combination With Docetaxel in Patients With Advanced Malignancies | 2008 | 5 |
About Brad Thompson
Brad Thompson is a scholar working on Infectious Diseases, Genetics, Biotechnology, Animal Science and Zoology and Oncology, having authored 23 papers that have together received 961 indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Viral gastroenteritis research and epidemiology (12 papers), Animal Virus Infections Studies (3 papers), Cancer Research and Treatments (3 papers), CAR-T cell therapy research (3 papers), Viral Infections and Outbreaks Research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). The work is most often cited by research in Genetics (739 citations), Biotechnology (183 citations), Infectious Diseases (297 citations), Oncology (389 citations) and Animal Science and Zoology (76 citations). Brad Thompson has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Matt C. Coffey, Peter A. Forsyth, Don G. Morris, David H. George, Mark G. Hamilton, Cheryl Ann Palmer, Kevin Joseph Harrington, Hardev Pandha, Gloria B. Roldán and James M. Markert. Their work appears in journals such as Gene Therapy, Biomedicines, Clinical Cancer Research, Investigational New Drugs and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.